Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Elevated alanine transaminase in liver transplant recipients after BNT162b2 vaccination: a cohort study

by Willemoe, Gro Linno , Bock, Ask , Bergmann, Jacob Siewertsen , Fialla, Annette Dam , Villadsen, Gerda Elisabeth , Pedersen, Christian Ross , Nielsen, Susanne Dam , Holland-Fischer, Peter , Heidari, Safura-Luise , Hamm, Sebastian Rask , Bering, Louise

in 631/154/1438 / 631/250/590/2293 / 631/326/596/4130 / 692/699/1503/1607 / Biomedical and Life Sciences / Biomedicine / Biopsy / Cholangitis / Cohort analysis / COVID-19 vaccines / Hepatitis / Infectious Diseases / Liver / Liver diseases / Liver transplants / Medical Microbiology / mRNA vaccines / Polymerase chain reaction / Public Health / Severe acute respiratory syndrome coronavirus 2 / Vaccine / Vaccines / Virology

2025

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Elevated alanine transaminase in liver transplant recipients after BNT162b2 vaccination: a cohort study

2025

Confirm

Do you wish to request the book?

Elevated alanine transaminase in liver transplant recipients after BNT162b2 vaccination: a cohort study

2025

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Elevated alanine transaminase in liver transplant recipients after BNT162b2 vaccination: a cohort study

Willemoe, Gro Linno,

Bock, Ask,

Bergmann, Jacob Siewertsen,

Fialla, Annette Dam,

Villadsen, Gerda Elisabeth,

Pedersen, Christian Ross,

Nielsen, Susanne Dam,

Holland-Fischer, Peter,

Heidari, Safura-Luise,

Hamm, Sebastian Rask,

Bering, Louise

2025

Overview

Liver transplant (LTx) recipients risk severe COVID-19. Vaccination reduces this risk. However, there may be side effects, including elevated alanine transaminase (ALT) which could lead to increased use of liver biopsy. We aimed to describe prevalence and relative incidence of elevated ALT 90 days before and after BNT162b2 vaccination in LTx recipients. Furthermore, we aimed to describe changes in prevalence of liver biopsies before and after BNT162b2 vaccination. We included 393 LTx recipients from The Danish Comorbidity in Liver Transplant Recipients (DACOLT) study. We calculated prevalence of elevated ALT and liver biopsies before and after each BNT162b2 vaccine dose. We used self-control case series (SCCS) analysis to investigate whether vaccination was associated with higher relative incidence of elevated ALT. Prevalence of elevated ALT, around each vaccine dose, was comparable. We did not find higher relative incidence of elevated ALT after vaccination. The prevalence of liver biopsies around vaccination was comparable.

Share this book

Add to My Shelf

Publisher

Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio

Subject

/ Biomedical and Life Sciences

/ Biomedicine

/ Biopsy